These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8574685)

  • 1. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram.
    Invernizzi R; Bramante M; Samanin R
    Brain Res; 1995 Oct; 696(1-2):62-6. PubMed ID: 8574685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis.
    Hjorth S; Auerbach SB
    Neuropharmacology; 1994; 33(3-4):331-4. PubMed ID: 7984270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats.
    Yoshitake T; Kehr J
    Life Sci; 2004 Apr; 74(23):2865-75. PubMed ID: 15050424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
    Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
    Hjorth S; Westlin D; Bengtsson HJ
    Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors.
    Invernizzi R; Bramante M; Samanin R
    Eur J Pharmacol; 1994 Aug; 260(2-3):243-6. PubMed ID: 7988650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
    Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
    Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
    Tao R; Ma Z; Auerbach SB
    J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
    Gundlah C; Hjorth S; Auerbach SB
    Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
    Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
    Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
    Casanovas JM; Lésourd M; Artigas F
    Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
    Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function.
    Gonzalez LE; Parada MA; Tucci S; Teneud L; Overstreet DH; Hernandez L
    Braz J Med Biol Res; 2003 Feb; 36(2):263-7. PubMed ID: 12563529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
    Stenfors C; Yu H; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.